| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2021 | Mar 26, 2021 | Ernexa Therapeutics Inc. | CEO | Sell | 46.3 | -9,944 | -6.97% | ✗ | $26.6K |
| Mar 19, 2021 | Mar 22, 2021 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -207 | -0.14% | ✗ | $730.7 |
| Feb 19, 2021 | Feb 22, 2021 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -207 | -0.14% | ✗ | $995.7 |
| Jan 19, 2021 | Jan 20, 2021 | Ernexa Therapeutics Inc. | CEO | Sell | 47.5 | -2,987 | -2.04% | ✗ | $7.6K |
| Dec 19, 2020 | Dec 21, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -170 | -0.12% | ✗ | $368.9 |
| Nov 20, 2020 | Nov 20, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -170 | -0.12% | ✗ | $319.6 |
| Oct 21, 2020 | Oct 21, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 47.5 | -2,453 | -1.65% | ✗ | $5K |
| Sep 22, 2020 | Sep 23, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -170 | -0.11% | ✗ | $338.3 |
| Aug 25, 2020 | Aug 26, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -170 | -0.11% | ✗ | $445.4 |
| Jul 28, 2020 | Jul 28, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 47.5 | -2,453 | -1.62% | ✗ | $4.5K |
| Jun 29, 2020 | Jun 30, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -170 | -0.11% | ✗ | $535.5 |
| May 20, 2020 | May 20, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -164 | -0.11% | ✗ | $254.2 |
| Apr 21, 2020 | Apr 22, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 47.5 | -2,363 | -1.53% | ✗ | $2.9K |
| Mar 25, 2020 | Mar 25, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -207 | -0.14% | ✗ | $306.4 |
| Feb 25, 2020 | Feb 26, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -285 | -0.20% | ✗ | $584.3 |
| Jan 19, 2020 | Jan 31, 2020 | Ernexa Therapeutics Inc. | CEO | Sell | 90.0 | +79,817 | 131.06% | ✗ | $692.6 |
| Dec 19, 2019 | Dec 20, 2019 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -242 | -0.40% | ✗ | $660.7 |
| Nov 20, 2019 | Nov 20, 2019 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -241 | -0.39% | ✗ | $631.4 |
| Oct 23, 2019 | Oct 23, 2019 | Ernexa Therapeutics Inc. | CEO | Sell | 52.5 | -241 | -0.39% | ✗ | $694.1 |
| Sep 24, 2019 | Sep 24, 2019 | Ernexa Therapeutics Inc. | CEO | Sell | 47.5 | -722 | -1.16% | ✗ | $1.6K |
| Aug 27, 2019 | Aug 27, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -141 | -0.23% | ✗ | $390.6 |
| Jul 30, 2019 | Jul 30, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -141 | -0.23% | ✗ | $448.4 |
| Jun 21, 2019 | Jun 24, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -141 | -0.22% | ✗ | $489.3 |
| May 21, 2019 | May 21, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -171 | -0.27% | ✗ | $494.2 |
| Apr 23, 2019 | Apr 25, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -171 | -0.27% | ✗ | $649.8 |
| Mar 26, 2019 | Mar 27, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -171 | -0.27% | ✗ | $636.1 |
| Feb 26, 2019 | Feb 26, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -171 | -0.32% | ✗ | $584.8 |
| Jan 29, 2019 | Jan 29, 2019 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -171 | -0.32% | ✗ | $543.8 |
| Dec 19, 2018 | Dec 20, 2018 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -145 | -0.27% | ✗ | $290 |
| Nov 20, 2018 | Nov 20, 2018 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -144 | -0.27% | ✗ | $413.3 |
| Oct 23, 2018 | Oct 24, 2018 | Ernexa Therapeutics Inc. | CFO | Sell | 52.5 | -145 | -0.27% | ✗ | $626.4 |
| Sep 25, 2018 | Sep 25, 2018 | Ernexa Therapeutics Inc. | CFO | Sell | 47.5 | -857 | -1.56% | ✗ | $3.6K |
| Jun 13, 2016 | Jun 14, 2016 | Ernexa Therapeutics Inc. | CFO | Buy | 90.0 | +15,000 | 18.63% | ✗ | $1.8K |
| Mar 16, 2016 | Mar 16, 2016 | Ernexa Therapeutics Inc. | CFO | Buy | 90.0 | +15,000 | 11.03% | ✗ | $2.8K |
| May 21, 2015 | May 21, 2015 | Ernexa Therapeutics Inc. | CFO | Buy | 91.3 | +65,500 | 100.00% | ✗ | $23.6K |